Table 1.

Age and numbers of cholera patients and vaccinees enrolled in this study

	Specimen tested	Vibrio cholerae O1 serotype	No. of patients or vaccinees	Median age in yr (25th, 75th percentile)
Vaccinees	ASC*		15	27 (23, 35)
	Plasma†		33	32 (26, 39)
	MBC-CS†		24	33 (28, 40)
Patients	ASC‡	Ogawa	12	31 (20, 40)
	Plasma§	Ogawa	17	29 (26, 33)
	MBC-CS§	Ogawa	14	36 (29, 44)

^*Specimens were analyzed on Day 0 before vaccination and on follow-up Days 7, 21 (7 days after 2nd dose of vaccine), and 42.

^†Analyzed on Days 0, 3, 17 (3 days after 2nd dose of vaccine), 42, 90, 180, 270, 360.

^‡Analyzed on Days 2, 7, 30.

^§Analyzed on Days 2, 7, 30, 90, 180, 270, 360.

ASC = antibody-secreting cell assay; MBC-CS = memory B cell assay using culture supernatant.